Ortho Fused Rings In Acid Moiety Patents (Class 560/80)
  • Patent number: 9850408
    Abstract: The present invention relates to an optical adhesive film which has excellent adhesive strength at room temperature and has improved efficiency in a rework process since peel strength is low at high temperatures. When attaching a touchscreen panel and an LCD by using the adhesive film of the present invention and separating the touchscreen panel and the LCD at high temperatures, the touchscreen panel and the LCD can be separated from each other without causing damage thereto. Additionally, the optical film of the present invention comprises two adhesive layers, wherein peeling occurs at the first adhesive layer having an adhesive composition such that a peeling surface can be controlled according to the convenience of a user.
    Type: Grant
    Filed: January 8, 2013
    Date of Patent: December 26, 2017
    Assignee: LG Chem, Ltd.
    Inventors: Chan Oh Yoon, Jang Soon Kim, Min Seok Song, Eun Kyung Park, Bu Gi Jung
  • Patent number: 9410040
    Abstract: Disclosed herein is a method for preparing large soluble graphenes. The method comprises attaching one or more hindering groups to the graphene, which can prevent face-to-face graphene stacking by reducing the effects of inter-graphene attraction. The large graphenes can absorb a wide spectrum of light from UV to near infrared, and are useful in photovoltaic devices and sensitizers in nanocrystalline solar cells.
    Type: Grant
    Filed: January 7, 2011
    Date of Patent: August 9, 2016
    Assignee: Indiana University Research and Technology Corporation
    Inventors: Liang-shi Li, Xin Yan
  • Patent number: 9238609
    Abstract: Disclosed herein are phenylindane dicarboxylic acid (PIDA) monomers, polymer compositions comprising the PIDA monomers, and methods of preparing PIDA monomers. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
    Type: Grant
    Filed: May 23, 2014
    Date of Patent: January 19, 2016
    Assignee: SABIC Global Technologies B.V.
    Inventors: Navinchandra Asthana, Kiran Arunkumar Puthamane, Shantaram Narayan Naik, Minor Senthil Kumar, Venkata Ramanarayanan Ganapathy Bhotla, Vinodkumar Vasudevan, Edward J. Nesakumar, Girish Chandra, Ruud van der Heijden, Jan Henk Kamps, Elena Uliyanchenko, Robert R. Gallucci
  • Patent number: 9056998
    Abstract: Novel crystalline compounds with at least two aromatic moieties for use in the phase change inks. The crystalline compound is derived from bio-renewable materials and can be used in phase change ink compositions to impart desirable ink properties. For example, the crystalline compounds provide phase change ink compositions suitable for ink jet printing, including robust printing on coated paper substrates.
    Type: Grant
    Filed: October 14, 2013
    Date of Patent: June 16, 2015
    Assignee: XEROX CORPORATION
    Inventors: Adela Goredema, Guerino Sacripante, Kentaro Morimitsu, Naveen Chopra, Stephan V. Drappel
  • Publication number: 20150105579
    Abstract: Novel crystalline compounds with at least two aromatic moieties for use in the phase change inks. The crystalline compound is derived from bio-renewable materials and can be used in phase change ink compositions to impart desirable ink properties. For example, the crystalline compounds provide phase change ink compositions suitable for ink jet printing, including robust printing on coated paper substrates.
    Type: Application
    Filed: October 14, 2013
    Publication date: April 16, 2015
    Applicant: XEROX CORPORATION
    Inventors: ADELA GOREDEMA, Guerino Sacripante, Kentaro Morimitsu, Naveen Chopra, Stephan V. Drappel
  • Patent number: 9005478
    Abstract: A liquid crystal composition comprising a chiral dopant compound represented by the following structure (Structure 1): wherein: R1 and R2 are independently hydrogen, —(C?O)R9, —(C?O)R10, alkyl, aryl, alkaryl, alkenyl, cycloalkyl, alkoxyaryl, or heterocyclic all either substituted or unsubstituted, or combine to form a carbocyclic or heterocyclic ring; R3 is hydrogen, halogen, cyano, alkoxy, NHCOR9, NHSO2R9, COOR9, OCOR9, aryl, alkyl, alkenyl, cycloalkyl, or heterocyclic all either substituted or unsubstituted; R4 is hydrogen, alkyl, aryl, alkenyl, cycloalkyl, or heterocyclic all either substituted or unsubstituted; R5, R6, R7, and R8 are independently hydrogen, halogen, cyano, alkoxy, NHCOR9, NHSO2R9, COOR9, OCOR9, aryl, alkyl, alkenyl, cycloalkyl, alkoxyaryl or heterocyclic all either substituted or unsubstituted, or combine with each other, or R5 can combine with R4 to form a carbocyclic or heterocyclic ring; R9 and R10 are independently alkyl, alkoxy, aryl, naphthyl, styryl, alkenyl, cycloalkyl, alko
    Type: Grant
    Filed: January 6, 2014
    Date of Patent: April 14, 2015
    Assignees: Kent Displays Incorporated, Kent State University
    Inventors: Donald R. Diehl, Erica N. Montbach
  • Publication number: 20140249199
    Abstract: The disclosure relates to TAK1 inhibitors, compositions, and uses related thereto. In certain embodiments, the disclosure relates to compounds of formula (I), pharmaceutical compositions having a compound of formula (I), and methods of treating or preventing cancer by administering an effective amount of a pharmaceutical composition having a compound of formula (I) to a subject in need thereof.
    Type: Application
    Filed: July 19, 2012
    Publication date: September 4, 2014
    Applicants: HEALTH RESEARCH, INC., EMORY UNIVERSITY
    Inventors: Huw M. L. Davies, Spandan Chennamadhavuni, Andrei Bakin
  • Publication number: 20140221330
    Abstract: An objective of the present invention is to provide a novel NDM (New Delhi metallo-?-lactamase) inhibitor that functions as a drug for restoring the antibacterial activity of ?-lactam antibiotics that have been inactivated as a result of decomposition by NDM.
    Type: Application
    Filed: July 26, 2012
    Publication date: August 7, 2014
    Inventors: Akihiro Morinaka, Kazunori Maebashi, Takashi Ida, Muneo Hikida, Mototsugu Yamada, Takao Abe
  • Publication number: 20140209879
    Abstract: This invention relates to a method for making soluble precursors to imides, polyimides, and polymers containing imide groups, and a method of making thin films of the same by solution casting and then removing the solubilizing group to produce thermally stable and insoluble materials.
    Type: Application
    Filed: January 30, 2014
    Publication date: July 31, 2014
    Applicant: Colorado School of Mines
    Inventor: Daniel M. Knauss
  • Patent number: 8759474
    Abstract: Disclosed is a method for producing a liquid crystal polyester, which includes the steps of: (1) polycondensing a mixture of 70.5 to 71.5 mol % of a compound represented by the defined formula (I) (for example, 4-acetoxybenzoic acid) with 28.5 to 29.5 mol % of a compound represented by the defined formula (II) (for example, 6-acetoxy-2-naphthoic acid) to form a prepolymer, wherein the prepolymer has a flow initiation temperature of 200° C. or higher, and the mixture is polycondensed until reaching the temperature which is at least 30° C. lower than the polycondensation temperature; (2) removing the prepolymer in a molten state, followed by solidification and further grinding to produce prepolymer particles; and (3) subjecting the prepolymer particles to a heat treatment at 200 to 310° C. under circulation of an inert gas while remaining in a solid phase state.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: June 24, 2014
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Shinji Ohtomo, Yusaku Kohinata, Hidehiro Kotaka
  • Patent number: 8709281
    Abstract: A liquid crystal composition comprising a chiral dopant compound represented by the following structure (Structure 1): wherein: R1 and R2 are independently hydrogen, —(C?O)R9, —(C?O)R10, alkyl, aryl, alkaryl, alkenyl, cycloalkyl, alkoxyaryl, or heterocyclic all either substituted or unsubstituted, or combine to form a carbocyclic or heterocyclic ring; and R3-R9 are as described in the disclosure. Also featured are liquid crystal compositions comprising a chiral dopant compound represented by any of Structure 2-4 as described in the disclosure.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: April 29, 2014
    Assignee: Kent State University
    Inventors: Donald R. Diehl, Erica N. Montbach
  • Publication number: 20140100384
    Abstract: Provided is a process for making non-phthalate plasticizers, by acylating an aromatic compound with a succinic anhydride to form a keto-acid, and then esterifying the keto-acid with C4-C13 OXO-alcohols to form a plasticizer compound. The aromatic rings of the aromatic compound may also be optionally hydrogenated.
    Type: Application
    Filed: December 9, 2013
    Publication date: April 10, 2014
    Applicant: ExxonMobil Research and Engineering Company
    Inventors: Jihad Mohammed Dakka, Edmund John Mozeleski, Lisa Saunders Baugh, Colle Karla Schall, Allen David Godwin, Diana S. Smirnova, Jorg Friedrich Wilhelm Weber, Stephen Zushma
  • Publication number: 20140044654
    Abstract: The present disclosure relates, according to some embodiments, to molecules, including conjugated fused polycyclic molecules, that may receive excited state energy from other molecules (e.g., light-absorbing molecules) or directly from the irradiation sources. According to some embodiments, the disclosure relates to molecules, including conjugated fused polycyclic molecules, that may resolve (e.g., quench, dissipate) excited state energy, normally by way of releasing it as heat. (e.g., as heat). Conjugated fused polycyclic molecules of various structures are disclosed including Formula III: The disclosure further relates to methods of use and/or therapy using molecules of Formulas I, II, and/or III.
    Type: Application
    Filed: August 9, 2013
    Publication date: February 13, 2014
    Applicant: HALLSTAR INNOVATIONS CORP.
    Inventors: Craig A. Bonda, Shengkui Hu, Qing Jean Zhang, Zhihui Zhang
  • Publication number: 20130237627
    Abstract: A crosslinkable curing super-branched polyester and the cured product and the preparation method thereof are disclosed. The super-branched polyester has high refractive index and comprises a compound represented by the following structural formula (I). In the formula (I), HBP is the backbone of the super-branched polyester; both a and b are positive integers; the sum of a and b is less than or equal to n; n is more than or equal to 10 and less than 80. In the super-branched polyester, A is represented by formula (II) and N is represented by formula (III), wherein R is methyl or hydrogen atom; the mole ratio of N relative to the total mole of A and N is more than 30 mol %, and the ratio of the total mole of A and N relative to the product of the total mole of HBP backbone and n is more than 0.5 and less than or equal to 1.
    Type: Application
    Filed: November 15, 2010
    Publication date: September 12, 2013
    Applicant: SHANGHAI WEIKAI CHEMICALS CO., LTD.
    Inventors: Mingdong Yu, Zhi Chen
  • Patent number: 8481129
    Abstract: A liquid crystal compound of Formula (I) is provided. In Formula (I), A is benzene, naphthalene, pyridine, furan, thiophene or a single bond, D is benzene, naphthalene, pyridine, furan, thiophene or a single bond, R1 and R2 are C1-10 alkyl, C1-10 alkoxy, fluoro or trifluoro methyl, E is benzene, naphthalene, pyridine, furan, thiophene or a single bond, W is —CO—O—, —O—CO—, —O—, —CH2—CH2—, —CH?CH—, —CH2—O— or a single bond, Z is benzene, naphthalene, pyridine, furan, thiophene or a single bond, Y is hydrogen, methyl, ethyl or propyl, m is 0, 1 or 2, p is 0, 1 or 2, r is 0, 1 or 2, q is 0, 1 or 2, and n is 0, 1, 2 or 3. The invention also provides a liquid crystal display and photochromic material including the compound.
    Type: Grant
    Filed: December 29, 2011
    Date of Patent: July 9, 2013
    Assignee: Industrial Technology Research Institute
    Inventors: Yi-Rong Wang, Chih-Lung Chin, Wan-Chi Chen, Kung-Lung Cheng, Shih-Hsien Liu
  • Publication number: 20130172558
    Abstract: Naproxen-based ferroelectric liquid crystal (FLC) or nematic liquid crystal chiral compounds, which can be used in liquid crystal compositions useful for electro-optical and display device applications. The liquid crystal can be a ferroelectric liquid crystal. Also provided is a display device that includes the Naproxen-based ferroelectric liquid crystal (FLC) or nematic liquid crystal chiral compound. Also provided is a method of preparing a liquid crystal display device on silicon that includes incorporating the Naproxen-based ferroelectric liquid crystal (FLC) or nematic liquid crystal chiral compound, into a liquid crystal display on silicon by disposing the compound in a liquid crystal, or the liquid crystal, onto a silicon surface.
    Type: Application
    Filed: January 4, 2012
    Publication date: July 4, 2013
    Inventors: Yongqiang Zhang, Kundalika More, William Thurmes
  • Patent number: 8449953
    Abstract: An embodiment of the invention provides a chiral dopant having the following formula: wherein X1 and X2 are independently wherein F is fluorine, m is a positive integer from 1 to 8, and n is a positive integer from 1 to 4; Y1 and Y2 are independently —O—, —CH2CH2—, —CH?CH—, —C(O)O—, or —CH2O—; and R1, R2 are independently substituted or non-substituted C1-C10 linear alkyl, wherein substituents of the substituted C1-C10 linear alkyl are independently —F, —Cl, —OCF3, —NCS, or —CN, wherein a number of backbone carbon atoms in each of —Y1R1 and —Y2R2 is larger than 3.
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: May 28, 2013
    Assignee: Industrial Technology Research Institute
    Inventors: Chien-Hsien Cheng, Kuo-Chang Wang, Chun-Ming Wu, Kung-Lung Cheng, Shih-Hsien Liu, Chih-Lung Chin
  • Patent number: 8431731
    Abstract: Disclosed is a method for reducing the appearance of a fine line or wrinkle on skin comprising topically applying to said fine line or wrinkle a composition comprising a glyceryl di-salicylate compound having the following structure: wherein the composition further includes a glyceryl mono-salicylate compound, and wherein the composition reduces the appearance of said fine line or wrinkle on skin.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: April 30, 2013
    Assignee: Mary Kay Inc.
    Inventors: Anton A. Mentlik, James Swanzy
  • Publication number: 20130071785
    Abstract: It is an object of the present invention to provide a new alcohol compound, a polyester resin, an unsaturated polyester resin, a resin particle and an electrophotographic toner using the compound capable of using the renewable resources as a part of a raw material. An alcohol compound according to the present invention is characterized by representing the chemical formula [Chemical 1]. Furthermore, the polyester resin or the unsaturated polyester resin according to the present invention, is characterized in that the compound (wherein X is an aliphatic or an aromatic residue, Y is a refined rosin residue, a disproportionated rosin residue or a hydrogenated rosin residue, and n=0 to 1 in the formula.) is an essential component of an alcohol component. Further, the resin particle of the present invention is characterized by comprising the polyester resin.
    Type: Application
    Filed: March 2, 2011
    Publication date: March 21, 2013
    Applicant: Japan U-Pica Company, Ltd.
    Inventors: Tetsuji Moroiwa, Nobutaka Yoshida, Hiroshi Aihara, Akira Yamane, Kei Yamasaki, Keiko Taniuchi
  • Patent number: 8394468
    Abstract: Provided is a polymerizable compound with large solubility in a liquid crystal composition and high reactivity irradiated by ultraviolet in the longer wavelength range. Provided is a liquid crystal composition that satisfies at least one of characteristics such as high maximum temperature of a nematic phase, low minimum temperature of a nematic phase, small viscosity, suitable optical anisotropy, large negative dielectric anisotropy, large specific resistance, high stability to ultraviolet light and high stability to heat, or that is suitably balanced between at least two of the characteristics.
    Type: Grant
    Filed: May 7, 2010
    Date of Patent: March 12, 2013
    Assignees: JNC Corporation, JNC Petrochemical Corporation
    Inventors: Maiko Ito, Keiji Kimura, Norikatsu Hattori, Eriko Saegusa
  • Publication number: 20130032758
    Abstract: Described herein are devices, compositions, and methods for improving color discernment.
    Type: Application
    Filed: August 2, 2012
    Publication date: February 7, 2013
    Inventors: Brett T. Harding, Sheng Li, Amane Mochizuki
  • Patent number: 8344175
    Abstract: The invention relates to compounds of Formula (I): The invention further relates to liquid crystal compositions comprising compounds of Formula (I); compositions further comprising one or more chiral compounds; and polymer networks derived from the polymerization of the liquid crystal compositions. Another embodiment relates to processes for providing compounds of Formula (I).
    Type: Grant
    Filed: January 25, 2011
    Date of Patent: January 1, 2013
    Assignee: E I du Pont de Nemours and Company
    Inventors: Marc B. Goldfinger, Jose Manuel Rodriguez-Parada, Lee A. Silverman
  • Patent number: 8323527
    Abstract: The invention relates to novel fluorene derivatives, which are especially suitable for use in birefringent films with negative optical dispersion, to novel liquid crystal (LC) formulations and polymer films comprising them, and to the use of the fluorene derivatives, formulations and films in optical, electrooptical, electronic, semiconducting or luminescent components or devices.
    Type: Grant
    Filed: August 18, 2008
    Date of Patent: December 4, 2012
    Assignee: Merck Patent GmbH
    Inventors: Kevin Adlem, Owain Llyr Parri, Karl Skjonnemand, David Wilkes
  • Publication number: 20120289734
    Abstract: A three-stage method for synthesizing 1,1-disubstituted olefins is provided.
    Type: Application
    Filed: April 27, 2012
    Publication date: November 15, 2012
    Applicant: Henkel AG & Co. KGaA
    Inventors: Carsten Friese, Dieter Kaufmann, Vasu Govardhana Reddy Peddiahgari
  • Publication number: 20120289471
    Abstract: The present invention is directed to novel therapeutic compounds comprised of an amino acid bonded to a medicament or drug having a hydroxy, amino, carboxy or acylating derivative thereon. These high therapeutic index derivatives have the same utility as the drug from which they are made, and they have enhanced pharmacological and pharmaceutical properties. In fact, the novel drug derivatives of the present invention enhance at least one therapeutic quality, as defined herein. The present invention is also directed to pharmaceutical compositions containing same.
    Type: Application
    Filed: April 18, 2012
    Publication date: November 15, 2012
    Applicant: SIGNATURE R&D HOLDINGS, LLC
    Inventor: V. Ravi Chandran
  • Publication number: 20120253060
    Abstract: Disclosed is a method for producing a liquid crystal polyester, which includes the steps of: (1) polycondensing a mixture of 70.5 to 71.5 mol % of a compound represented by the defined formula (I) (for example, 4-acetoxybenzoic acid) with 28.5 to 29.5 mol % of a compound represented by the defined formula (II) (for example, 6-acetoxy-2-naphthoic acid) to form a prepolymer, wherein the prepolymer has a flow initiation temperature of 200° C. or higher, and the mixture is polycondensed until reaching the temperature which is at least 30° C. lower than the polycondensation temperature; (2) removing the prepolymer in a molten state, followed by solidification and further grinding to produce prepolymer particles; and (3) subjecting the prepolymer particles to a heat treatment at 200 to 310° C. under circulation of an inert gas while remaining in a solid phase state.
    Type: Application
    Filed: March 23, 2012
    Publication date: October 4, 2012
    Applicant: SUMITOMO CHEMICAL COMPANY, LIMITED
    Inventors: Shinji OHTOMO, Yusaku KOHINATA, Hidehiro KOTAKA
  • Patent number: 8247158
    Abstract: The present invention refers to new organic molecules, derived from the class of polycarbocycle derivatives, and their application as components of photoresists, and in particular as components of photoresist compositions where no polymer is comprised as one of the photoresists components. In these photoresist formulations the new molecule(s) is/are the main component(s) (i.e. percentage higher than 50% w/w).
    Type: Grant
    Filed: September 18, 2006
    Date of Patent: August 21, 2012
    Inventors: Panagiotis Argitis, Evangelos Gogolides, Elias Couladouros, Dimitra Niakoula, Veroniki Vidali, Daman R. Gautam
  • Patent number: 8197710
    Abstract: A polymerizable compound represented by general formula (1): wherein Z1 and Z2 each represent a (meth)acryloyloxy group; X1 and X2 each independently represent a single bond, an optionally branched alkylene group having 1 to 8 carbon atoms, an ether linkage, —COO—, —OCO—, —OCOO—, a 6-membered ring optionally having a substituent, or a combination thereof; R1 represents —R?, —OR?, —CO—R?, or —OCO—R?; R? represents a halogen atom, an optionally branched alkyl group having 1 to 8 carbon atoms, or a 6-membered ring optionally having a substituent, L1 and L2 each independently represent a member selected from a single bond, —CH2CH2—, —CH?CH—, —C?C—, —CH2O—, —OCH2—, —COO—, and —OCO—; m represents an integer of 1 to 4; and the R1's may be the same or different.
    Type: Grant
    Filed: October 9, 2007
    Date of Patent: June 12, 2012
    Assignee: Adeka Corporation
    Inventors: Rieko Hamada, Masatomi Irisawa, Kiyoshi Murata
  • Patent number: 8163806
    Abstract: The present invention relates to the discovery of biodegradable multi-armed oligomers wherein the end groups of these oligomers have been functionalized with biologically active molecules. The resultant multi-armed oligomers end-functionalized with biologically active molecules have a controllable degradation profile. The hydrolytic degradation of oligomers of the present invention releases the biologically active compound as such with no change in native chemical structure.
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: April 24, 2012
    Assignee: Bezwada Biomedical, LLC
    Inventor: Rao S Bezwada
  • Publication number: 20120088869
    Abstract: Organic materials which possess outstanding stability to oxidative, thermal or light-induced degradation comprise as stabilizers at least one compound of the formula I wherein the general symbols are as defined in claim 1. The compounds of formula I are especially useful as stabilizers for protecting polymers and lubricants against oxidative, thermal or light-induced degradation and as scavengers for oxidized developer in color photographic material.
    Type: Application
    Filed: December 20, 2011
    Publication date: April 12, 2012
    Inventors: Michèle GERSTER, Peter NESVADBA
  • Patent number: 8115197
    Abstract: An organic semiconductor material is provided. The organic semiconductor material includes a polyacene derivative expressed by the following general formula (1): where each of R1 to R10 may be independently the same substituents or different substituents but all of R1, R4, R5, R6, R9 and R10 may never be hydrogen atoms at the same time, and where each of R1 to R10 is at least one kind of substituent selected from the group consisting of an aliphatic hydrocarbon group having a substituent and of which number of carbon atoms ranges of from 1 to 20, an aromatic hydrocarbon group having a substituent, a complex aromatic group having a substituent, a carboxyl group, a hydride, an ester group, a cyano group, a hydroxyl group, a halogen atom and a hydrogen atom. The organic semiconductor material can be dissolved into an organic solvent at low temperature (for example, room temperature) and is suitable for use with a coating process.
    Type: Grant
    Filed: May 31, 2006
    Date of Patent: February 14, 2012
    Assignees: Sony Corporation, National University Corporation Hokkaido University
    Inventors: Takahiro Ohe, Noriyuki Kawashima, Tamotsu Takahashi, Ken-Ichiro Kanno
  • Publication number: 20120010284
    Abstract: The present invention relates to the discovery of biodegradable multi-armed oligomers wherein the end groups of these oligomers have been functionalized with biologically active molecules. The resultant multi-armed oligomers end-functionalized with biologically active molecules have a controllable degradation profile. The hydrolytic degradation of oligomers of the present invention releases the biologically active compound as such with no change in native chemical structure.
    Type: Application
    Filed: September 19, 2011
    Publication date: January 12, 2012
    Applicant: BEZWADA BIOMEDICAL, LLC
    Inventor: Rao S. Bezwada
  • Patent number: 8048496
    Abstract: The purpose the invention is to provide a polymerizable liquid crystal compound which has an excellent solubility with other compounds, a high homeotropic property, and a spirobiindan-backbone, and a liquid crystal composition comprising this compound. The purpose is attained with a polymerizable liquid crystal compound represented by Formula (1). A polymer which is excellent in many characteristics can be obtained from this compound and a formed body having optical anisotropy, produced from this polymer can be obtained. In Formula (1), G is a single bond or oxygen; R is hydrogen, methyl (Me) or a group represented by Formula (a), wherein at least two of R are groups represented by Formula (a); P is a polymerizable group represented by any of Formula (P1) to Formula (P8). In Formula (a), a desirable A is 1,4-cyclohexylene or 1,4-phenylene; Z is a bonding group; m is an integer of 0 to 3; X0 is a single bond or alkylene; Z0 is a single bond, —O—, —OCO—, or —OCOO—; X is a single bond or alkylene.
    Type: Grant
    Filed: September 25, 2009
    Date of Patent: November 1, 2011
    Assignee: JNC Corporation
    Inventors: Maiko Itoh, Yoshiharu Hirai, Junichi Inagaki, Daisuke Ootsuki
  • Patent number: 8044228
    Abstract: This invention relates to liquid crystal compositions, and polymer networks and articles comprising the compositions. The compositions comprise at least one compound of the group of compounds represented by the structures of each of the following Formulas (IV), (V) and (VI), as defined herein. A process for making the composition is also provided.
    Type: Grant
    Filed: June 8, 2009
    Date of Patent: October 25, 2011
    Assignee: E.I. du Pont de Nemours and Company
    Inventor: Marc B. Goldfinger
  • Publication number: 20110251158
    Abstract: Described herein are methods for treating inflammatory disorders or for inhibiting the build-up of arterial plaque. The methods comprise administering to a subject in need thereof a therapeutically effective amount of a synthetically modified fullerene.
    Type: Application
    Filed: September 16, 2010
    Publication date: October 13, 2011
    Applicant: Luna Innovations Incorporated
    Inventors: Christopher L. KEPLEY, Robert P. LENK, Darren K. MACFARLAND, Zhiguo ZHOU
  • Publication number: 20110232944
    Abstract: A liquid crystalline thermoset oligomer or polymer including a structural unit of Chemical Formulae 1 and 2; and a functional group of Chemical Formula A,
    Type: Application
    Filed: December 13, 2010
    Publication date: September 29, 2011
    Applicants: SAMSUNG ELECTRONICS CO., LTD., SAMSUNG ELECTRO-MECHANICS CO., LTD., SAMSUNG FINE CHEMICALS CO., LTD.
    Inventors: Jae-Jun LEE, Kalinina FEDOSYA, Myung-Sup JUNG
  • Publication number: 20110190251
    Abstract: Disclosed herein are methods of inhibiting the build-up of arterial plaque in a subject in need thereof. These methods comprise administering to the subject in need thereof a therapeutically effective amount of fullerenes.
    Type: Application
    Filed: March 3, 2009
    Publication date: August 4, 2011
    Inventors: Christopher L. Kepley, Robert P. Lenk, Stephen R. Wilson, Zhiguo Zhou
  • Patent number: 7985455
    Abstract: The compound of the present invention is represented by the formula (1). In the formula (1), R1 and R2 are hydrogen, fluorine, chlorine, methyl or ethyl; X1 and X2 are hydrogen, fluorine, methyl or trifluoromethyl; Z1 and Z2 are a single bond, —COO—, —OCO—, —CH?CH—COO—, —OCO—CH?CH—, —CH2CH2—COO—, —OCO—CH2CH2—, —CH2O—, —CONH—, —(CH2)4—, —CH2CH2— or —C?C—; Z3 and Z4 are a single bond or —O—; A1 and A2 are 1,4-cyclohexylene, 1,4-phenylene, 1,3-phenylene, pyridin-2,5-diyl, pyrimidin-2,5-diyl, naphthalen-2,6-diyl or tetrahydronaphtlane-2,6-diyl; and Y1 and Y2 are alkylene having from 2 to 20 carbon atoms.
    Type: Grant
    Filed: May 7, 2010
    Date of Patent: July 26, 2011
    Assignees: JNC Corporation, Chisso Petrochemical Corporation
    Inventors: Junichi Inagaki, Tomohiro Yano, Daisuke Ootsuki, Maiko Ito, Ryushi Shundo
  • Publication number: 20110123468
    Abstract: Described is the use of benzotropolone and their derivatives, especially the compounds of formula (1); wherein R2, R3, R4, R5 and R6 independently of one another are hydrogen; OH; C1-C30alkyl, C2-C30al-kenyl, C1-C30alkoxy, C3-C12cycloalkyl or C1C30hydroxyalkyl, which may be substituted by one or more E and/or interrupted by one or more D; C6-C20aryl, which may be substituted by one or more G; C4-C20heteroaryl, which may be substituted by one or more G, C2-C18alkenyl, C2-C18alkynyl, C7-C25aralkyl, CN, or —CO—R17; C1-C30mono- or dialkylamino; COR9; COOR9; CONR9R10; CN; SO2R9; OCOOR9; OCOR9; NHCOOR9; NR9COR10; NH2; *—(CO)—NH—(CH2)n1—(PO)—(OR11)2; —(CO)—O—(CH2)n1—(PO)—(OR11)2; sulphate; sulphonate; phosphate; phosphonate; —(CH2)n2—[O—(SO2)]n3—OR11; —O—(CH2)n4(CO)n5—R11; —(O)n6—(CH2)n7—(PO)—(OR9)2; —(O)n6—(CH2)n7—SO2—OR9; halogen; organosilanyl; organo-siloxanyl; or a sugar residue linked directly in an ?- or ?-mode via the anomeric oxygen to the benzotropolone system or via a linear or branched alkylene, alkenyle
    Type: Application
    Filed: June 18, 2009
    Publication date: May 26, 2011
    Applicant: BASF SE
    Inventors: Barbara Wagner, Reinhold Ohrlein, Bernd Herzog, Kai Eichin, Gabriele Baisch, Stephanie Portmann
  • Publication number: 20110114885
    Abstract: The invention relates to compounds of Formula (I): The invention further relates to liquid crystal compositions comprising compounds of Formula (I); compositions further comprising one or more chiral compounds; and polymer networks derived from the polymerization of the liquid crystal compositions. Another embodiment relates to processes for providing compounds of Formula (I).
    Type: Application
    Filed: January 25, 2011
    Publication date: May 19, 2011
    Applicant: E. I. DU PONT DE NEMOURS AND COMPANY
    Inventors: MARC B. GOLDFINGER, Jose Manuel Rodriguez-Parada, Lee A. Silverman
  • Publication number: 20110086073
    Abstract: The present invention describes nanoprodrugs of non-steroidal anti-inflammatory drug (NSAIDs) and nanoprodrugs of ?-lipoic acid-containing and NSAIDs. These nanoprodrugs have antioxidant properties and stimuli-responsiveness, which can be used to treat various disease conditions.
    Type: Application
    Filed: April 8, 2009
    Publication date: April 14, 2011
    Applicant: Cedars-Sinai Medical Center
    Inventors: John S. Yu, Bong Seop Lee
  • Patent number: 7879256
    Abstract: The invention relates to compounds of Formula (I): The invention further relates to liquid crystal compositions comprising compounds of Formula (I); compositions further comprising one or more chiral compounds; and polymer networks derived from the polymerization of the liquid crystal compositions. Another embodiment relates to processes for providing compounds of Formula (I).
    Type: Grant
    Filed: March 30, 2007
    Date of Patent: February 1, 2011
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Marc B. Goldfinger, Jose Manuel Rodriguez-Parada, Lee A. Silverman, Kai Qi
  • Publication number: 20110003909
    Abstract: It's object is to provide a (meth)acrylate compound excellent in photocurability, a curable composition comprising the compound and excellent in all of pattern accuracy, peelability, surface hardness, elasticity recovery and solvent resistance, an optical nanoimprint composition and a cured product of the curable composition and a method for producing it, especially to provide a composition favorable for a permanent film for flat panel displays, etc. A (meth)acrylate compound represented by the following formula (1): wherein R1 represents a hydrogen atom or a methyl group, R2 represents a substituent having carbon atoms of 2 to 6 and having a carbon-carbon double bond, X represents an organic group having carbon atoms of 1 to 10, m and n each are an integer of 1 to 3.
    Type: Application
    Filed: March 4, 2009
    Publication date: January 6, 2011
    Inventors: Akinori Fujita, Takashi Takayanagi, Hiroyuki Yonezawa
  • Publication number: 20100301271
    Abstract: The invention relates to novel fluorene derivatives, which are especially suitable for use in birefringent films with negative optical dispersion, to novel liquid crystal (LC) formulations and polymer films comprising them, and to the use of the fluorene derivatives, formulations and films in optical, electrooptical, electronic, semiconducting or luminescent components or devices.
    Type: Application
    Filed: August 18, 2008
    Publication date: December 2, 2010
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Kevin Adlem, Owain Llyr Parry, Karl Skjonnemand, David Wilkes
  • Publication number: 20100274040
    Abstract: The present invention relates to 1,1?-bi-2-naphthol derivatives having (meth)acrylate groups, which can be used for preparing photocurable coating and has a refractive index of 1.53 or more. By using the present 1,1?-bi-2-naphthol derivatives, optical components with high refractive index and less light dispersion can be produced.
    Type: Application
    Filed: July 8, 2009
    Publication date: October 28, 2010
    Inventors: Cheng Chao PAI, Hsiu Chi Lai, Ching Ying Wu, Kun Lin Lee
  • Publication number: 20100264367
    Abstract: The compound of the present invention is represented by the formula (1). In the formula (1), R1 and R2 are hydrogen, fluorine, chlorine, methyl or ethyl; X1 and X2 are hydrogen, fluorine, methyl or trifluoromethyl; Z1 and Z2 are a single bond, —COO—, —OCO—, —CH?CH—COO—, —OCO—CH?CH—, —CH2CH2—COO—, —OCO—CH2CH2—, —CH2O—, —CONH—, —(CH2)4—, —CH2CH2— or —C?C—; Z3 and Z4 are a single bond or —O—; A1 and A2 are 1,4-cyclohexylene, 1,4-phenylene, 1,3-phenylene, pyridin-2,5-diyl, pyrimidin-2,5-diyl, naphthalen-2,6-diyl or tetrahydronaphtlane-2,6-diyl; and Y1 and Y2 are alkylene having from 2 to 20 carbon atoms.
    Type: Application
    Filed: May 7, 2010
    Publication date: October 21, 2010
    Inventors: Junichi Inagaki, Tomohiro Yano, Daisuke Ootsuki, Maiko Ito, Ryushi Shundo
  • Publication number: 20100233628
    Abstract: A compound represented by the formula (I): wherein R1 represents a hydrogen atom etc., R2 and R3 each independently represent a hydrogen atom etc., R4 represents a C1-C8 divalent hydrocarbon group, R5 represents a single bond etc., and R6 represents an unsubstituted or substituted C6-C20 aromatic hydrocarbon group, a polymer comprising a structural unit derived from the compound represented by the formula (I) and a chemically amplified positive resist composition comprising the polymer, at least one acid generator and at least one solvent.
    Type: Application
    Filed: March 8, 2010
    Publication date: September 16, 2010
    Applicant: SUMITOMO CHEMICAL COMPANY, LIMITED
    Inventors: Makoto AKITA, Isao Yoshida, Kazuhiko Hashimoto
  • Publication number: 20100222543
    Abstract: Improved process for the continuous production of slow crystallizing polyester resin comprising esterification of at least one dicarboxylic acid or mono-esters thereof or di-esters thereof with at least one polyol, melt polymerizing the esterified mixture, preparing uniform crystalline hemispherical prepolymer by particle former process, adding at least one diol having tertiary or quaternary carbon atoms with pendant groups such as neopentyl glycol or 2-methyl-1,3-propanediol or any suitable diol at any stage during esterification or melt polymerization but before the particle former process; and solid state polymerizing the prepolymer to obtain high molecular weight slow crystallizing polyester. Slow crystallizing low molecular weight crystalline hemispherical prepolymer having IV of about 0.1 dl/g to about 0.45 and uniform hemispherical shape, uniform particle size, uniform crystallinity prepared by the above process and is used as precursor to prepare high molecular weight resin.
    Type: Application
    Filed: August 14, 2006
    Publication date: September 2, 2010
    Applicant: Reliance Industries Ltd
    Inventors: Vikas Madhusudan Nadkarni, Srinivasacharya Ramacharya Ayodhya, Shreeram Ashok Wadekar, Ashwin Kumar Jain, Sachin Narayan Rane, Chetan Vijay Limaye
  • Publication number: 20100209469
    Abstract: The present invention provides NO and, optionally, drug releasing macromers and oligomers wherein the drug molecule and NO releasing moiety are linked an absorbable macromer or oligomeric chain susceptible to hydrolytic degradation and wherein the macromer or oligomer comprises of repeat units derived from safe and biocompatible molecules such as glycolic acid, lactic acid, caprolactone and p-dioxanone. Furthermore, the present invention relates to controlled release of nitric oxide (NO) and/or drug molecule from a NO and drug releasing macromer or oligomer. Moreover, the present invention also relates to medical devices, medical device coatings and therapeutic formulations comprising of nitric oxide and drug releasing macromers and oligomers of the present invention.
    Type: Application
    Filed: July 24, 2009
    Publication date: August 19, 2010
    Applicant: BEZWADA BIOMEDICAL, LLC.
    Inventor: Rao S. Bezwada
  • Patent number: 7771616
    Abstract: A polymerizable liquid crystal compound of formula (1). The compound has high optical (refractive index) anisotropy (?n), exhibits a liquid crystal phase at room temperature (having a broad liquid crystal phase temperature range) without crystallization, has high solubility in cyclohexanone, methyl ethyl ketone or like organic solvents, exhibits excellent coating properties and orientation properties, and, after polymerization, has high transparency. wherein R1 and R2 each represent hydrogen, a methyl group or halogen; rings A to C each represent a benzene ring, a naphthalene ring, etc.; at least one of rings A to C is a fused ring; X, Y, and Z each represent a C1 to C6 alkyl group, etc.; L1, L2, and L3 each represent —COO—, —OCO—, —O(CH2)j— (j=1 to 8), etc.; n is 0 or 1, and a to c are numbers such that the polymerizable liquid crystal compound may have at least one of X, Y, and Z.
    Type: Grant
    Filed: August 24, 2006
    Date of Patent: August 10, 2010
    Assignee: Adeka Corporation
    Inventors: Masatomi Irisawa, Tatsunori Kobayashi, Mineki Hasegawa